Objective. To investigate markers of endothelial activation in muscle biopsies from rheumatoid arthritis (RA) patients with and without extra-articular manifestations (ExRA).
Rheumatoid arthritis (RA) is a chronic disease characterized by inflammatory polyarthritis, which in some cases is complicated by extra-articular manifestations (ExRA). The latter range from mild signs of serositis, which may only be detectable at autopsy w1x, to lifethreatening necrotizing vasculitis involving internal organs w2x. In a well-defined RA population, the majority of clinically evident ExRA is made up of cases of pleuritis, pericarditis and cutaneous vasculitis w3x. The systemic nature of RA is further underlined by the presence of fever and weight loss in severe cases w4x.
RA has consistently been found to be associated with an increased mortality rate compared with the general population w5-7x, and most of the excess mortality is due to cardiovascular deaths w7, 8x. The mortality among patients with ExRA has been found to be even higher than among non-extra-articular RA patients w3, 9, 10x. A subset of ExRA patients with a poor prognosis has been defined w3, 11x, and cardiovascular mortality appears to be particularly increased in this subgroup w3x.
The mechanism behind the increased risk of cardiovascular death in RA and in ExRA in particular is not known, but chronic inflammation has been suggested as a risk factor for cardiovascular death in RA and ExRA; this is probably related to atherosclerotic vascular disease w8x. Soluble forms of intercellular adhesion molecule 1 (ICAM-1) and other cellular adhesion molecules have been detected in serum in increased amounts in patients with RA w12x as well as in other chronic diseases with established blood vessel involvement, such as systemic vasculitis w13x and systemic sclerosis w14x. In a comparison of RA patients with and without vasculitis, circulating ICAM-1 concentrations were significantly higher in the vasculitis subgroup w15x. In addition, in longitudinal studies of apparently healthy men w16x and women w17x, the soluble form of ICAM-1 (sICAM-1) was found to be an important predictor of cardiovascular disease. These findings are compatible with generalized blood vessel involvement in at least subgroups of RA patients, and could be important in the pathogenesis of cardiovascular disease.
Muscle tissue is well suited to the investigation of blood vessels, as it is easy to biopsy and the muscle tissue from the extremities usually contains both microvessels and small arteries w18x. Vascular involvement in skeletal muscle in ExRA has been reported, including necrotizing arteritis w19x in a small number of patients with muscular symptoms. Vasculitis has also been reported in striated muscle biopsies from RA patients who clinically presented signs of vasculitis in other organs (e.g. neuropathy and cutaneous lesions) w20, 21x, and a pattern of increased expression of adhesion molecules and HLA-DR in muscle tissue has been reported from such patients without histopathological evidence of vasculitis w22x.
The present study was undertaken in order to investigate whether there is more generalized endothelial activation in patients with extra-articular manifestations of RA than in non-extra-articular RA patients. We studied the expression of markers of endothelial activation and inflammation in skeletal muscle tissue and in serum from RA patients with and without extra-articular manifestations.
Materials and methods

Patients
Nine patients with previously diagnosed RA, all fulfilling the 1987 American College of Rheumatology classification criteria for RA w23x, who developed extraarticular manifestations according to predefined criteria w3, 11, 37x were included in the study. The patients were recruited from rheumatology out-patient clinics in Malmö (n = 8) and Ä ngelholm (n = 1). Their ExRA consisted of pleuritis (n = 2), pericarditis (n = 2), Felty's syndrome (n = 2) or cutaneous vasculitis (n = 3). Briefly, in the patients with pericarditis and pleuritis, clinically suspected exudation was verified by echocardiography and chest X-ray respectively. The patients with Felty's syndrome had splenomegaly by ultrasound measurement, neutrophils < 1.8 3 10 9 ul on at least two occasions, and no other probable explanation of the neutropenia. Cutaneous vasculitis was diagnosed by biopsy (n = 2) or clinical judgement by a dermatologist (n = 1). Arterial or venous insufficiency to the extent that could explain the lesions was not present. All cases were examined by the same physician (CT) before inclusion. RA controls without ExRA, matched for age, sex and duration of RA, were selected from a database (established in 1997) containing all known RA patients attending out-patient clinics run by rheumatologists in Malmö . Only controls fulfilling the 1987 American College of Rheumatology criteria for RA w23x were included. Previous and current absence of ExRA (according to the same criteria as the cases, in addition including the absence of rheumatoid nodules) in the controls was verified by evaluation of medical records, a detailed questionnaire and physical examination. Patients with previous or current rheumatoid nodules were excluded, as nodules have been shown to predict severe extra-articular disease w37x and inclusion of nodular patients in the non-ExRA group would put them at risk of developing ExRA. All cases and controls were examined by the same physician (CT), using a structured protocol. ExRA cases and non-ExRA controls were well matched for sex (three men and six women in each group), age wExRA, median 61 yr; interquartile range (IQR) 58-69 yr; non-ExRA, 59 yr, 54-66 yr) and duration of RA (ExRA, median 15 yr, IQR 6-23; non-ExRA 17 yr, 7-20 yr). There was no major difference in the number of current smokers (ExRA 2, non-ExRA 1), previous smokers (ExRA 6, non-ExRA 5) or in systolic blood pressure (ExRA, median 130, IQR 120-140; non-ExRA 130, 120-145). There was no substantial difference in the number of individuals previously positive for RF (78% in both groups) or antinuclear antibodies (ExRA 38%, non-ExRA 25%). ExRA patients tended to be on glucocorticoid treatment (22 vs 56%) (P = 0.33) and treatment with disease-modifying anti-rheumatic drugs (DMARDs) (56 vs 100%) (P = 0.082) to a lesser extent than non-ExRA controls at the time when they developed the ExRA manifestation. The patients with ExRA tended to have a higher number of swollen joints wmedian 8, IQR 5-19 vs 2 (0-4)x (P = 0.09), higher scores for Ritchie's index (median 16, IQR 8-19 vs 5, 2-8) (P = 0.42) and higher levels of C-reactive protein (CRP) (median 31 mgul, IQR 13-64 vs10, 0-21) (P = 0.12).
None of the RA patients had muscle pain, weakness or other clinical signs of muscle disease. All patients gave their informed consent to participation and the study was approved by the ethics committee of Lund University.
Tissue samples
Muscle biopsy was performed before any changes in pharmacological treatment were made due to the extraarticular manifestations. Biopsies from the vastus lateralis or the tibialis anterior muscle were obtained from each patient under local anaesthesia using a semi-open technique with a conchotome w24x. At least two biopsy samples were taken from each patient, snap-frozen in isopentane chilled with liquid nitrogen, and stored at 2 708C. Muscle tissues from five healthy subjects with normal histopathological findings and no clinical symptoms of muscle pain and muscle weakness served as controls. Sections from a patient with severe inclusion body myositis, with a known profile of expression of inflammatory cytokines and HLA-molecules, were used as a positive control.
Two slides from each patient (taken from the levels flanking the sections used for immunohistochemistry studies) were evaluated by a neuropathologist (IN) after staining with haematoxylin and eosin. All slides were coded and analysed blindly for the presence of degeneration, regeneration, atrophy, centrally located nuclei and inflammatory infiltrates.
Immunohistochemistry studies
Cryostat sections 7 mm thick were mounted on gelatincoated glass slides (Cell-line Associates, Newfield, NJ, USA) and air-dried for 30 min at room temperature. The sections were stored unfixed at 2708C until stained. A standard immunohistochemistry protocol w25x was used to stain for cell type-specific antigens and HLA molecules. Briefly, the sections were acetone-fixed and endogenous peroxidase was blocked with 1% hydrogen peroxide and 2% sodium nitride. Antibodies to lymphocyte functioning-associated antigen 1 (LFA-1a) or CD11a (clone G52.2) were kindly provided by Manuel Patarroyo, MTC, Stockholm, Sweden. Antibodies to CD3 (clone SK7), CD4 (clone SK3), CD8 (clone SK1), CD20 (clone L27), HLA-DQ (clone SK10) and HLA-DR (clone L243) were purchased from Becton Dickinson, San Jose, CA, USA. Antibodies to CD19 (clone HD37), CD68 (clone PGM1), CD163 (clone Ber-MAC3) and HLA-ABC (clone W6u32) were purchased from Dako, Glostrup, Denmark. Antibodies to ICAM-1 and CD54 (clone 84H10) were purchased from Serotec, Oxford, UK. Antibodies to vascular cell adhesion molecule-1 (VCAM-1) or CD106 (clone 51-10C9) were purchased from Pharmingen, San Diego, CA, USA. Antibodies to very late activation antigen 4a (VLA-4a) and CD49d (clone HP2u1) were purchased from Immunotech, Marseille, France. Antibodies to IL-1a (clones 1277-89-7, 1277-82-29 and 1279-143-4) were purchased from Towbin Heusser, Basel, Switzerland. Normal horse serum (1%) was added in order to reduce background caused by interaction of tissue IgG and Fc receptors with the Fc region of the secondary antibodies. A biotinylated secondary antibody was used wbiotin-horse anti-mouse IgG (Vector, Burlingame, CA, USA)x and, after addition of avidin-biotin peroxidase complex, the stain was developed using 3-amino-9-ethylcarbazole. Staining for IL-1a was performed as described previously w18x, using a modified immunohistochemistry protocol for intracellular staining with saponin as detergent w26x.
Quantitation of stained cells
The tissue sections were analysed with a Reichert-Jung Polyvar microscope. Quantitation was performed both by conventional microscopy and by computer-assisted imaging analysis. For the conventional reading, the numbers of positively stained mononuclear cells and endothelial cells of the whole tissue section were estimated. The origin of the muscle biopsies was concealed to the investigators during the quantitation. The sections were read on different occasions by two of the authors (CT and IEL) with concordant results. Mean values of these readings were divided by the total tissue area of the biopsy, measured by computer image analysis (see below).
The numbers of mononuclear cells per unit area of cryocut section stained positively for the markers CD3, CD4, CD8, CD68 and CD163 in combination, CD19 and CD20 in combination, LFA-1 and VLA-4 were determined in the same way. The number of cells and vessels stained positively for VCAM-1, ICAM-1 and HLA-DQ were scored separately; only the number of positive vessels is given in the results as no extra information was derived from this subdivision. For HLA-ABC and HLA-DR staining, a 5-point scale was used to score the percentage of positively stained muscle fibre area relative to the total section area: 0 = positive staining in endothelial cells, negative muscle fibres; 1+= 1-10% of the fibre area; 2+= 11-25%; 3 + = 26-50%; 4 + = 51-100%.
Computer image analysis
For stainings that featured a large number of positive vessels or large positive areas, computer image analysis was used to quantify the stained areas. IL-1a and HLA-DQ staining was analysed by image analysis. The images were assessed in a Quantimet 600 (Q600) image analyser (Leica Cambridge, Cambridge, UK). The image processor was controlled by a computer (PC). Special software was written for this application, in a highlevel language (QUIPS). The results of the image analysis showed the positively stained area as a percentage of the total tissue section area. Image analysis was also used to assess the total biopsy specimen area in mm 2 . Mean values of three measured sections from each biopsy were used.
Circulating cytokines, adhesion molecules and rheumatoid factors Blood was drawn immediately after the muscle biopsy was taken. Serum was stored at 2 208C and was available from seven ExRA patients and nine RA controls for the analysis of circulating cytokines, soluble adhesion molecules and RF isotypes, which was performed by a blinded investigator (LT). The ExRA patients subject to serum analysis suffered from pleuritis (n = 2), cutaneous vasculitis (n = 3), pericarditis (n = 1) and Felty's syndrome (n = 1). Tumour necrosis factor a (TNF-a) was measured with an automated immunoassay system, Immulite (DPC, Los Angeles, CA, USA). sICAM-1, soluble VCAM-1 (sVCAM-1), soluble E-selectin and soluble L-selectin were measured by enzyme-linked immunosorbent assay (ELISA) using kits from R&D Systems (Minneapolis, MN, USA). IgM, IgG and IgA RF isotypes were analysed by ELISA as described previously w27x, which was calibrated against the WHO RF reference preparation.
Statistical analysis
Fisher's exact test was used to assess differences between the ExRA and non-ExRA groups regarding previous RF and antinuclear antibody status and current treatment with DMARDs and corticosteroids. In comparisons of other clinical parameters and the results of serum analysis and immunohistochemistry studies, the paired t-test was used for parameters with a normal distribution (i.e. pairwise differences between cases and controls in areas positive for IL-1a by computer image analysis and pairwise differences for IgM RF titres). The results are presented as mean pairwise differences and 95% confidence intervals. For parameters without a normal distribution, the Wilcoxon signed rank test was used, and the results are presented as median pairwise differences and P values for between-group differences. Correlations between clinical, serological and immunohistochemical variables were investigated using Spearman's correlation test.
Results
Histopathological assesment
In haematoxylinueosin-stained sections, single, small, perivascular, cellular infiltrates were noted in one ExRA patient and one non-ExRA patient. There were, however, no inflammatory cell infiltrates surrounding or invading the muscle fibres and no signs of fibre degeneration. Specific staining showed scattered cells featuring CD3, CD4, CD8, CD68u163, CD19u20, LFA-1a and VLA-4, without differences between the groups.
Interleukin-1a and adhesion molecules in muscle tissue IL-1a was expressed in endothelial cells of arterioles, venules and capillaries. The patients with ExRA had more extensive staining for IL-1a, especially in the arterioles (Fig. 1) . The total area stained for IL-1a (by computer image analysis) was greater in ExRA patients than in non-ExRA controls with RA wmean pairwise difference 0.26%, 95% confidence interval (95% CI): 0-0.52x. The area stained in non-ExRA patients did not differ substantially from that in the healthy controls (Fig. 3) . There was no difference in IL-1a expression between patients on glucocorticosteroid treatment and non-glucocorticoid-treated patients (P = 1.0). The size of the positive area correlated with the number of swollen joints wSpearman's correlation coefficient (r) = 0.51; P = 0.03x in the total group studied, but not in the ExRA (r = 0.14; P = 0.71) or non-ExRA group (r = 00.42; P = 0.23) when studied separately. There was no correlation between IL-1a expression and CRP or Ritchie's index.
ICAM-1 and VCAM-1 expression in endothelium and infiltrating cells was limited, without major differences between the groups (Table 1) .
MHC class I and II expression
HLA-ABC and -DR antigens were expressed in the endothelium of most blood vessels in ExRA patients, non-ExRA patients and healthy controls, without obvious differences between the groups. Expression of HLA-DQ, on the contrary, was highly variable, from being almost absent in some samples to being present in hundreds of capillaries in some. The endothelium of the capillaries of some extensively stained sections from ExRA patients had a thickened appearance when stained for HLA-DQ (Fig. 2a) , resembling the high endothelial venules of lymph nodes. The number of stained capillaries (by manual scoring) was significantly increased in ExRA patients (median 22.5umm 2 , IQR 15.9-74.6 vs 7.9, 5.9-15.5) (P = 0.039). There was also a trend towards a larger HLA-DQ-positive tissue area, as assessed by computer image analysis, in ExRA patients (median 0.28%, IQR 0.086-1.03 vs 0.10, 0.058-0.12) (P = 0.074) than in non-ExRA patients. There was a correlation between the number of HLA-DQ-positive capillaries and the total DQ-positive area in the total group studied (r = 0.75, P = 0.0003) as well as in the ExRA and non-ExRA subgroups separately. The HLA-DQ staining pattern in non-ExRA patients did not differ from that in the healthy controls (Fig. 4) . There was no correlation between HLA-DQ expression and disease activity parameters (number of swollen joints, Ritchie's index and CRP) in RA patients; this applied to the analysis of all the RA patients together and of the ExRA and non-ExRA groups studied separately.
HLA-ABC expression in muscle fibres was detected in five ExRA patients, five non-ExRA RA patients and one healthy control. In five sections, more than 10% of the muscle fibres (by visual scoring) were HLA-ABCpositive. Four of these had ExRA (one with Felty's syndrome, two with pericarditis and one with cutaneous vasculitis) and one was a control RA patient.
Muscle fibres stained for HLA-DR were present in two ExRA patients, both of whom had presented with pericarditis. A relatively small number of fibres (<10%) were stained in both cases.
Serum analysis
Serum concentrations of TNF-a, sICAM-1, sVCAM-1 and IgM RF were significantly higher in the ExRA group ( Table 2 ). The concentrations of TNF-a and sICAM-1 were highly correlated (r = 0.68, P = 0.003). TNF-a and sICAM-1 correlated with the number of swollen joints when all the RA patients were analysed as one group, but not in the two groups when studied separately. IgM RF levels were higher in the ExRA group (mean pairwise difference 938 IUuml, 95% CI 182-1694), and IgM RF levels correlated with the number of HLA DQ-positive capillaries (r = 0.56, P = 0.02).
Discussion
In this systematic immunohistochemical study of muscle tissue, the expression of HLA-DQ and IL-1a was increased in the endothelium of blood vessels in skeletal muscle tissue of RA patients with ExRA compared with those without extra-articular manifestations. This occurred in the absence of clinical and histopathological signs of localized inflammation in the muscle tissue studied, indicating that the abnormal IL-1a and HLA-DQ expression may be a general feature of the vascular system of ExRA patients. Elevated serum levels of sICAM-1, sVCAM-1 and TNF-a were also found in ExRA patients compared with the non-ExRA controls. Concentrations of RF, in particular IgM RF, were also increased in ExRA. Moreover, IgM RF levels correlated with the number of capillaries expressing HLA-DQ in muscle tissue.
The ExRA cases included in this study manifested a spectrum of different systemic features of RA. They fulfilled the Malmö criteria for extra-articular disease, which have been demonstrated to identify patient groups with an increased mortality rate, especially in vascular disease, compared to RA patients in general w3, 11x. The present findings may thus be of relevance to the comorbidity and mortality associated with extra-articular RA.
The immunohistochemical protocols used in this study have previously been used extensively in studies of inflammatory myopathies w18, 26, 28x. We used computer image analysis to assess the staining of relatively small numbers of large areas (as in the case of the arteriolar staining for IL-1a), as the total area stained was considered to reflect the amount of cytokines produced rather than the number of positive arterioles. We relied on conventional microscopy when the stained areas (cells and microvessels) were small and the visual counting of numbers instead of the percentage stained area was considered to be more accurate (e.g. when staining for lymphocyte and macrophage CD markers, adhesion molecules). In the case of HLA-DQ expression, for which the biopsies varied both in the number of stained vessels and in the area stained in each vessel, both methods were used, and we demonstrated a correlation between the number of stained capillaries (assessed by conventional microscopy) and the stained area (measured by image analysis).
The increased serum concentrations of TNF-a and sICAM-1 in the ExRA group, which did not correlate with the immunohistochemical findings, illustrate that several different inflammatory pathways may be involved in systemic RA. TNF-a is recognized as an important factor in the pathogenesis of RA w29x. Treatment with TNF-blocking agents reduces the serum level of sICAM-1 w30x and decreases clinical and laboratory signs of disease activity w31, 32x, although the specific effect on extra-articular manifestations has not been evaluated.
In a recent study of rheumatoid vasculitis, increased expression of the adhesion molecules ICAM-1 and VCAM-1 and of HLA-DR was observed in muscle biopsy specimens from vasculitis patients with and without perivascular infiltrates, compared with controls with non-vasculitic RA and osteoarthritis w22x. Expression of HLA-DQ and IL-1a was, however, not evaluated in that study. As the case definitions were different from the criteria for ExRA used in the present series, the results are not directly comparable.
The staining patterns observed in microvessels of muscle tissue in the present study resemble the findings described previously in endothelial cells of small blood vessels in the inflamed synovium of RA patients, where increased expression of IL-1a w33x and HLA-DQ w34, 35x was reported. On the contrary, synovial HLA-DQ expression in endothelial cells was not found in a group of patients with reactive arthritis w35x, suggesting that this finding is specific for microvessels of RA patients.
Increased endothelial IL-1a staining in muscle tissue has also been found in patients with inflammatory myopathies w18, 26x, but in the myositis patients IL-1a was expressed in the capillaries as well as in the arterioles, whereas in the present series the staining was more prominent in the arterioles. HLA-DQ expression in the endothelial cells of myositis patients was less prominent than in ExRA patients (unpublished data, own observations). This pattern may thus be characteristic of the rheumatoid disease process, and disseminated endothelial IL-1a and HLA-DQ expression could be important in the pathogenesis of ExRA. Felty's syndrome and rheumatoid vasculitis have been reported to be associated with the genetic subtype HLA-DQ7 w36x, and in a series of ExRA patients with a range of manifestations similar to those in the present patients, a trend towards an association with HLA-DQ7 was noted w37x. In the present series, there was a correlation between IgM RF levels and the number of HLA-DQ-positive capillaries in muscle tissue. A possible mechanism could be the induction of endothelial HLA-DQ expression by circulating immune complexes in genetically predisposed individuals.
The major limitations of the present study are the limited number of patients in each group, the possibility of significant findings due to multiple testing, and the possible influence of factors not controlled for in the analysis. The results should therefore be confirmed in a larger study. The distribution of ExRA manifestations was similar to that found in a retrospective survey of ExRA from a well-defined RA population w3x, indicating that the ExRA sample is representative of this subgroup of RA patients. The matching of control RA patients from the same catchment area for age, sex and disease duration should prevent selection bias among the controls as well as confounding by the potential risk factors for vascular disease. The non-ExRA patients all had non-nodular disease, as rheumatoid nodules are known predictors of severe extra-articular disease w37x. There was a trend towards fewer swollen joints in the non-ExRA patients at inclusion, but there was no correlation between joint count indices or CRP on one side and the expression of IL-1a or HLA-DQ on the other side, in either the ExRA or the non-ExRA group. It is, however, still possible that the increased HLA-DQ and IL-1a expression in the ExRA group may in part be explained by more widespread articular inflammation. The relative importance of this could be elucidated by stratification by the number of swollen joints in a larger series, but such an analysis was not possible for the present series. However, the vascular staining pattern described may be an important pathophysiological mechanism in systemic RA, regardless of whether it is determined in part by the extent of articular inflammation.
Endothelial activation has been defined as 'a quantitative change in the level of expression of specific gene products (i.e. proteins), which in turn endow endothelial cells with new capabilities that cumulatively allow endothelial cells to perform new functions' w38x. IL-1a expression has been reported in arteriosclerotic lesions, but not in normal blood vessels w39x. IL-1a induces tissue factor-like procoagulant activity and plasminogen activation inhibitor synthesis in human endothelial cells in vitro w40x, indicating that increased IL-1a production may have a procoagulant effect on vascular endothelium. MHC class II expression occurs in endothelial cells in some, but not all large blood vessels w41x, and has been found in endothelium overlying atherosclerotic plaques w42x. IL-1a and HLA-DQ may thus be important in atherosclerotic vascular disease. Endothelial activation of this sort could be important in other systemic inflammatory conditions, although this requires further study.
In conclusion, we have demonstrated increased expression of HLA-DQ and IL-1a in the endothelial cells of skeletal muscle blood vessels in patients with extra-articular manifestations of RA compared with non-extra-articular RA controls. This may indicate systemic endothelial activation in extra-articular RA. Serum levels of IgM RF, TNF-a and circulating sICAM-1 and sVCAM-1 were also increased in extraarticular RA compared with non-ExRA patients, indicating that several inflammatory pathways may be involved in extra-articular disease. Further studies should be performed in order to investigate possible associations between the immunohistochemical findings, individual extra-articular manifestations and other clinical features, including cardiovascular disease.
